ConductScience.org, home

Paper · 38415019

Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation.

Kjærgaard K and 11 others. JHEP Rep, 2024. Cited by 36 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation. Papers, record 38415019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38415019

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation.
PubMed
Journal
JHEP Rep
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
4.33
iCite
Revised in PubMed
2024-02-29
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kjærgaard KKristoffer
2Daugaard Mikkelsen ACAnne Catrine
3Landau AMAnne M
4Eriksen PLPeter Lykke
5Hamilton-Dutoit SStephen
6Magnusson NENils Erik
7Thomsen MBMajken Borup
8Chen FFenghua
9Vilstrup HHendrik
10Mookerjee RPRajeshwar Prosad

1 to 10 of 12Source PubMed

See all 12 authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121,119,734Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.Nat Rev Drug Discov2010https://conductscience.org/library/papers/21119734PubMed
223,046,210Review: systemic inflammation and Alzheimer's disease.Neuropathol Appl Neurobiol2013https://conductscience.org/library/papers/23046210PubMed
334,440,206Rifaximin Prevents T-Lymphocytes and Macrophages Infiltration in Cerebellum and Restores Motor Incoordination in Rats with Mild Liver Damage.Biomedicines2021https://conductscience.org/library/papers/34440206PubMed
428,314,735Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.Gut2017https://conductscience.org/library/papers/28314735PubMed
535,681,418Different Methods for Evaluating Microglial Activation Using Anti-Ionized Calcium-Binding Adaptor Protein-1 Immunohistochemistry in the Cuprizone Model.Cells2022https://conductscience.org/library/papers/35681418PubMed
637,425,212Role of ammonia in NAFLD: An unusual suspect.JHEP Rep2023https://conductscience.org/library/papers/37425212PubMed
733,961,787Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach.Lancet Gastroenterol Hepatol2021https://conductscience.org/library/papers/33961787PubMed
834,642,213Hippocampus-Prefrontal Coupling Regulates Recognition Memory for Novelty Discrimination.J Neurosci2021https://conductscience.org/library/papers/34642213PubMed
916,618,517Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.J Hepatol2006https://conductscience.org/library/papers/16618517PubMed
1033,572,481Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and Perspectives.J Clin Med2021https://conductscience.org/library/papers/33572481PubMed

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
42,689,015Liver-nervous system axis in MASLD: mechanistic insights and emerging targeted therapies.eGastroenterology2026https://conductscience.org/library/papers/42689015PubMed
42,566,291Suicide mortality in metabolic dysfunction-associated liver diseases: a nationwide cohort study.Ann Med2026https://conductscience.org/library/papers/42566291PubMed
42,483,871Closer Association of Liver Stiffness Than Liver Fat Content With Imaging-Derived Neurovascular Coupling in a Metabolic Dysfunction-Associated Steatotic Liver Disease Cohort.Diabetes Obes Metab2026https://conductscience.org/library/papers/42483871PubMed
42,465,741Exercise-conditioned extracellular vesicles in Alzheimer's disease: a multi-organ signaling network linking peripheral adaptation to brain pathology.Front Immunol2026https://conductscience.org/library/papers/42465741PubMed
42,451,045Ultra-Processed Foods, MASLD, and Cognitive Aging: A Processing-Centered Gut-Liver-Brain Axis Perspective.Nutrients2026https://conductscience.org/library/papers/42451045PubMed
42,409,068MASH-Associated T Cell Activation and Neuroinflammation: Evidence for a Hepatosystemic Immune Axis.Semin Liver Dis2026https://conductscience.org/library/papers/42409068PubMed
42,249,678Abdominal adiposity and Alzheimer's disease imaging markers across sex and race at midlife.J Alzheimers Dis2026https://conductscience.org/library/papers/42249678PubMed
42,183,943Agmatine protects against MAFLD via decreasing RBM15/IGF2BP2-mediated m6A modification of SREBP1.Mol Biol Rep2026https://conductscience.org/library/papers/42183943PubMed
42,120,765The Liver-brain Axis: A Three-stage Model Linking MASLD to Cognitive Impairment and Dementia.J Mol Neurosci2026https://conductscience.org/library/papers/42120765PubMed
42,020,485Impact of liver cirrhosis etiology on results of diagnostic tests for minimal hepatic encephalopathy.Sci Rep2026https://conductscience.org/library/papers/42020485PubMed

1 to 10 of 27

See all 27 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38415019

GET https://conductscience.org/api/papers/v1/38415019/references?page=2